
Exoskeleton Market by Product (Full Body, Lower Body, Upper Body), Type (Mobile, Stationary), Technology, End User - Global Forecast 2024-2030
Description
Exoskeleton Market by Product (Full Body, Lower Body, Upper Body), Type (Mobile, Stationary), Technology, End User - Global Forecast 2024-2030
The Exoskeleton Market size was estimated at USD 865.78 million in 2023 and expected to reach USD 999.81 million in 2024, at a CAGR 18.20% to reach USD 2,791.19 million by 2030.
Exoskeletons are used to support and assist movement or augment the physical capabilities, disabilities, or limitations resulting from disease or injury that enables patients with lower extremity weakness or partial paralysis to stand and walk on level surfaces. The increasing adoption of human exoskeletons in industrial & military sectors and elevating demand from the healthcare sector for robotic rehabilitation are propelling the market. Additionally, growing awareness and government initiatives for adopting exoskeletons in different industries present various opportunities to capitalize upon. However, the high equipment cost of an exoskeleton robot can pose a challenge to market penetration. Current regulatory issues for securing approvals for medical applications of exoskeletons may impede this progress moderately, given their complex structure. Market players have the opportunity to incorporate technological advancement in materials science, artificial intelligence, and robotics to increase the adoption of exoskeletons in different industries.
Regional Insights
The North American market is responsible for a significant share, including patients' high purchasing power, the growing geriatric population, and the public and private organizations offering grants and funds to develop technologically advanced products. On the other hand, Asia-Pacific is expected to register growth during the forthcoming years owing to a growing patient pool requiring rehabilitation support. Developing & advancing healthcare infrastructure and the availability of government support & funding are driving the development & growth of the exoskeleton market in Asia-Pacific. In Europe, non-manufacturing industries are adopting exoskeleton systems at large for rehabilitation, pick and carry, and other applications. The escalated maritime border tensions between the countries of Russia and Ukraine caused increased military spending worldwide as governments scrambled to upgrade their defensive systems and prepare for potential threats. Additionally, improving economic conditions, coupled with the rising demand for intelligent sensors for quality interaction between human and robotic devices, is expected to boost the exoskeleton market growth in Europe.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Exoskeleton Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Exoskeleton Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Exoskeleton Market, highlighting leading vendors and their innovative profiles. These include ABLE Human Motion S.L., American Bionics, Aselsan AS, ATOUN Inc., B-Temia Inc., Bioness Inc., Bionic Power Inc., BIONIK Inc., Bioservo Technologies AB, Bioventus LLC, Cyberdyne Inc., Dachser Group SE & Co. KG, Dephy Inc., Ekso Bionics Holdings Inc., ExoAtlet, Focal Meditech, Gogoa Mobility Robots, SL, Hilti Corporation, Hocoma AG, Honda Motor Co. Ltd., Honeywell International Inc., Hyundai Motor Company, Innophys Co., Ltd., Ktwo Healthcare Pvt. Ltd., Laevo, Levitate Technologies, Inc., Lockheed Martin Corporation, Marsi Bionics, S.L., Mitsubishi Heavy Industries, Ltd., Myomo, Inc., Noonee Germany GmbH, Northrop Grumman Corporation, Ottobock SE & Co. KGaA, Panasonic Corporation, Parker Hannifin Corporation, Raytheon Technologies Corporation, RB3D, Revision Inc., ReWalk Robotics Ltd., Rex Bionics Ltd., Rostec Corp., Safran S.A., Sarcos Corporation, SpringActive Inc., SRI International Inc., Suit X, Technaid, S.L., The Boeing Company, Toyota Motor Corporation, and Wearable Robotics s.r.l..
Market Segmentation & Coverage
This research report categorizes the Exoskeleton Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Full Body
Lower Body
Upper Body
Type
Mobile
Stationary
Technology
Active
Passive
End User
Hospitals
Manufacturing & Construction
Military & Defense
Rehabilitation Center
Sport & Fitness
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Exoskeleton Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Exoskeleton Market?
3. What are the technology trends and regulatory frameworks in the Exoskeleton Market?
4. What is the market share of the leading vendors in the Exoskeleton Market?
5. Which modes and strategic moves are suitable for entering the Exoskeleton Market?PDF E-mail From Publisher (2-5)Users License
Table of Contents
195 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Exoskeleton Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing demand from healthcare sector for robotic rehabilitation
- 5.1.1.2. Increasing adoption of human augmentation equipment in industrial and military sectors
- 5.1.1.3. Growth in the insurance coverage for medical exoskeletons
- 5.1.2. Restraints
- 5.1.2.1. High equipment cost of exoskeleton robots
- 5.1.3. Opportunities
- 5.1.3.1. Technological advancement in materials science, artificial intelligence, and robotics
- 5.1.3.2. Growing awareness and government initiatives for adoption of exoskeletons in different industries
- 5.1.4. Challenges
- 5.1.4.1. Regulatory issues for securing approvals for medical applications of exoskeletons
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Exoskeleton Market, by Product
- 6.1. Introduction
- 6.2. Full Body
- 6.3. Lower Body
- 6.4. Upper Body
- 7. Exoskeleton Market, by Type
- 7.1. Introduction
- 7.2. Mobile
- 7.3. Stationary
- 8. Exoskeleton Market, by Technology
- 8.1. Introduction
- 8.2. Active
- 8.3. Passive
- 9. Exoskeleton Market, by End User
- 9.1. Introduction
- 9.2. Hospitals
- 9.3. Manufacturing & Construction
- 9.4. Military & Defense
- 9.5. Rehabilitation Center
- 9.6. Sport & Fitness
- 10. Americas Exoskeleton Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Exoskeleton Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Exoskeleton Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 13.3.1. Merger & Acquisition
- 13.3.1.1. Ekso Bionics buys Indego exoskeletons from Parker Hannifin.
- 13.3.2. Agreement, Collaboration, & Partnership
- 13.3.2.1. Mubea to collaborate on production of carbon fiber exoskeletons.
- 13.3.2.2. Vanderbilt, 101st Airborne collaborate on development of exoskeleton for soldier use in inaugural Pathfinder Project.
- 13.3.2.3. Harmonic Bionics and Curexo Enter Strategic Partnership.
- 13.3.3. New Product Launch & Enhancement
- 13.3.3.1. Svaya Robotics unveils India’s first homegrown quadruped robot and exoskeleton.
- 13.3.4. Investment & Funding
- 13.3.4.1. Smart body suit for neuromuscular disease receives £1.25m (USD 1.56 million) backing.
- 13.3.4.2. RoboCT brings in USD 15 million for robotic exoskeletons.
- 13.3.5. Award, Recognition, & Expansion
- 13.3.5.1. Japanese startup seeks to expand abroad with exoskeleton business.
- 13.3.5.2. Human in Motion Robotics Awarded $663,000 Contract by Innovative Solutions Canada for Department of National Defense.
- 13.3.5.3. FDA Clears EksoNR Robotic Exoskeleton for Rehabilitation in Multiple Sclerosis.
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. ABLE Human Motion S.L.
- 14.1.2. American Bionics
- 14.1.3. Aselsan AS
- 14.1.4. ATOUN Inc.
- 14.1.5. B-Temia Inc.
- 14.1.6. Bioness Inc.
- 14.1.7. Bionic Power Inc.
- 14.1.8. BIONIK Inc.
- 14.1.9. Bioservo Technologies AB
- 14.1.10. Bioventus LLC
- 14.1.11. Cyberdyne Inc.
- 14.1.12. Dachser Group SE & Co. KG
- 14.1.13. Dephy Inc.
- 14.1.14. Ekso Bionics Holdings Inc.
- 14.1.15. ExoAtlet
- 14.1.16. Focal Meditech
- 14.1.17. Gogoa Mobility Robots, SL
- 14.1.18. Hilti Corporation
- 14.1.19. Hocoma AG
- 14.1.20. Honda Motor Co. Ltd.
- 14.1.21. Honeywell International Inc.
- 14.1.22. Hyundai Motor Company
- 14.1.23. Innophys Co., Ltd.
- 14.1.24. Ktwo Healthcare Pvt. Ltd.
- 14.1.25. Laevo
- 14.1.26. Levitate Technologies, Inc.
- 14.1.27. Lockheed Martin Corporation
- 14.1.28. Marsi Bionics, S.L.
- 14.1.29. Mitsubishi Heavy Industries, Ltd.
- 14.1.30. Myomo, Inc.
- 14.1.31. Noonee Germany GmbH
- 14.1.32. Northrop Grumman Corporation
- 14.1.33. Ottobock SE & Co. KGaA
- 14.1.34. Panasonic Corporation
- 14.1.35. Parker Hannifin Corporation
- 14.1.36. Raytheon Technologies Corporation
- 14.1.37. RB3D
- 14.1.38. Revision Inc.
- 14.1.39. ReWalk Robotics Ltd.
- 14.1.40. Rex Bionics Ltd.
- 14.1.41. Rostec Corp.
- 14.1.42. Safran S.A.
- 14.1.43. Sarcos Corporation
- 14.1.44. SpringActive Inc.
- 14.1.45. SRI International Inc.
- 14.1.46. Suit X
- 14.1.47. Technaid, S.L.
- 14.1.48. The Boeing Company
- 14.1.49. Toyota Motor Corporation
- 14.1.50. Wearable Robotics s.r.l.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. EXOSKELETON MARKET RESEARCH PROCESS
- FIGURE 2. EXOSKELETON MARKET SIZE, 2023 VS 2030
- FIGURE 3. EXOSKELETON MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. EXOSKELETON MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. EXOSKELETON MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. EXOSKELETON MARKET DYNAMICS
- FIGURE 7. EXOSKELETON MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 8. EXOSKELETON MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. EXOSKELETON MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 10. EXOSKELETON MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
- FIGURE 12. EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. EXOSKELETON MARKET SIZE, BY END USER, 2023 VS 2030 (%)
- FIGURE 14. EXOSKELETON MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS EXOSKELETON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS EXOSKELETON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES EXOSKELETON MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES EXOSKELETON MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC EXOSKELETON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC EXOSKELETON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. EXOSKELETON MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. EXOSKELETON MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.